- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Chest x-rays may increase likelihood of breast cancer
An analysis of 1600 women with BRCA1 and BRCA2 mutations suggests that exposure to chest x-rays may increase the risk of breast cancer. Exposure before the age of 20 may be linked to particularly heightened risk.
The research, conducted by a consortium of European cancer centers, was the first to analyze the impact of low-level x-ray exposure among women genetically at high risk for the disease (J Clin Oncol 2006;24[21]:3361-3366).
This is one of the first studies to demonstrate that women genetically predisposed to breast cancer may be more susceptible to low-dose ionizing radiation than other women. If the findings are confirmed in prospective studies, young women in families known to have BRCA1 or BRCA2 mutations may wish to consider alternatives to x-ray, such as MRI, investigators said.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
